ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
TSPO-PET highlights an atypical mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) phenotype.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe m.10158T > C mutation in the mitochondrial gene (MT-ND3) is a rare cause of adult-onset mitochondrial encephalopathy, typically presenting as MITOCHONDRIAL ENCEPHALOMYOPATHY WITH LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) with predominant cortical involvement. Early cerebellar onset and progressive atrophy are atypical. To investigate the underlying pathophysiology, we innovatively applied TSPO-PET to visualize neuroinflammation and MITOCHONDRIAL PATHOLOGY linked to mitochondrial encephalopathies. CASE PRESENTATION: A 32-year-old woman had a 20-year progressive disorder starting with migraines at age 12. Left cerebellar atrophy was found incidentally at 15, followed by episodic ataxia, dysarthria, and generalized seizures at 24. She later developed refractory status epilepticus, right side sensory ataxic symptoms, and neurocognitive decline. MRI showed progressive bilateral cerebellar atrophy and multifocal cortical lesions. Genetic testing identified the m.10158T > C mutation. TSPO-PET revealed increased uptake, indicating neuroinflammation, in the left thalamus, temporoparietal-occipital lobe, bilateral cerebellum, corresponding FDG-PET showed hypometabolism. Of note, the MRI-normal regions, including the right thalamus, hippocampus and brainstem, exhibited elevated TSPO uptake with or without subtle FDG changes.
conclusionOur study defined an atypical MELAS phenotype associated with m.10158T > C mutation, characterized by cerebellar early involvement, subsequent progressive atrophy, and repeated stroke-like episodes. In addition, TSPO-PET uptake extends well beyond the boundaries of detectable structural damage, demonstrating that molecular pathology exceeds visible damage. To our knowledge, our study represents the first preliminary exploration of in vivo histopathological changes using a second-generation TSPO radioligand (¹⁸F-DPA-714) in a patient with MELAS, advancing our understanding of the relationship between neuroinflammation and primary mitochondrial diseases.
Indexed as
Identifiers
41882155What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.